Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged

This investment product primarily channels its resources, typically committing a minimum of 95% of its net assets, into American Depositary Receipts (ADRs) that represent the B Shares of Novo Nordisk A/S. It's crucial to understand that direct investment in the company's underlying shares is not part of this series' strategy. Additionally, the fund is structured as non-diversified, indicating a concentrated portfolio.